Avita Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Avita Medical
RCEL Stock  USD 3.42  0.05  1.44%   
Avita Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Avita Medical's valuation are provided below:
Gross Profit
60.6 M
Profit Margin
(0.67)
Market Capitalization
105.8 M
Enterprise Value Revenue
1.7579
Revenue
72.4 M
There are over one hundred nineteen available fundamental signals for Avita Medical, which can be analyzed over time and compared to other ratios. We recommend to validate Avita Medical's prevailing fundamental drivers against the all of the trends between 2010 and 2026. At this time, Avita Medical's Working Capital is quite stable compared to the past year. Enterprise Value is expected to rise to about 343.3 M this year, although the value of Market Cap will most likely fall to about 190.1 M.

Avita Medical Total Revenue

77.58 Million

Check Avita Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avita Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 5.1 M or Selling General Administrative of 40.1 M, as well as many indicators such as Price To Sales Ratio of 5.63, Dividend Yield of 0.0 or PTB Ratio of 69.59. Avita financial statements analysis is a perfect complement when working with Avita Medical Valuation or Volatility modules.
  
Build AI portfolio with Avita Stock
Check out the analysis of Avita Medical Correlation against competitors.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.

Avita Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets96.3 M91.7 M55.4 M
Slightly volatile
Total Current Liabilities24.3 M23.2 M8.6 M
Slightly volatile
Total Stockholder Equity4.9 M5.2 M25.5 M
Slightly volatile
Cash11.3 M16.2 M17.6 M
Slightly volatile
Non Current Assets Total27.4 M26.1 M7.8 M
Slightly volatile
Cash And Short Term Investments43.3 M41.3 M31.6 M
Slightly volatile
Net Receivables14.4 M13.8 M4.2 M
Slightly volatile
Common Stock Shares Outstanding31.3 M29.8 M15.3 M
Slightly volatile
Liabilities And Stockholders Equity96.3 M91.7 M47.7 M
Slightly volatile
Non Current Liabilities Total66.5 M63.3 M14.6 M
Slightly volatile
Total Liabilities90.8 M86.5 M22.1 M
Slightly volatile
Total Current Assets68.8 M65.5 M49.2 M
Slightly volatile
Common Stock3.3 K3.5 K50.9 M
Slightly volatile
Inventory8.8 M8.4 M2.8 M
Slightly volatile
Other Current Assets2.3 M2.2 M1.7 M
Pretty Stable
Accounts Payable7.6 M7.2 M2.8 M
Slightly volatile
Property Plant And Equipment Net16.4 M15.6 M3.7 M
Slightly volatile
Common Stock Total Equity3.3 K3.5 K60.1 M
Slightly volatile
Property Plant And Equipment Gross20.6 M19.6 M4.6 M
Slightly volatile
Property Plant Equipment1.7 M2.4 M2 M
Very volatile
Net Invested Capital61.5 M53.8 M35.7 M
Slightly volatile
Net Working Capital58.6 M42.4 M33.4 M
Slightly volatile
Capital Stock2.6 K2.7 K84.2 M
Slightly volatile

Avita Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 M1.3 M461.4 K
Slightly volatile
Selling General Administrative40.1 M38.2 M15.8 M
Slightly volatile
Other Operating Expenses145.9 M139 M45.3 M
Slightly volatile
Total Operating Expenses134.9 M128.5 M43.5 M
Slightly volatile
Total Revenue77.6 M73.9 M21.4 M
Slightly volatile
Gross Profit66.6 M63.4 M17.9 M
Slightly volatile
Selling And Marketing Expenses70.3 M66.9 M19.7 M
Slightly volatile
Cost Of Revenue11 M10.5 M3.4 M
Slightly volatile
Research Development24.6 M23.4 M10.4 M
Slightly volatile
Interest Income67.6 K43.4 K73.8 K
Slightly volatile
Reconciled Depreciation1.4 M1.3 M457.3 K
Slightly volatile

Avita Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow13.8 M25.4 M23.9 M
Very volatile
Depreciation1.4 M1.3 M535.2 K
Slightly volatile
Stock Based Compensation16.3 M15.5 M5.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.635.9329.3442
Slightly volatile
PTB Ratio69.5966.2818.1284
Slightly volatile
Days Sales Outstanding74.2578.15102
Slightly volatile
Book Value Per Share0.190.22.3518
Slightly volatile
Invested Capital4.5 M7.4 M8 M
Slightly volatile
Average Payables102.7 K108.1 K436.9 K
Slightly volatile
Stock Based Compensation To Revenue0.230.240.6201
Slightly volatile
Capex To Depreciation7.837.463.478
Slightly volatile
PB Ratio69.5966.2818.1284
Slightly volatile
EV To Sales6.186.526.4766
Slightly volatile
Inventory Turnover1.371.442.5041
Slightly volatile
Days Of Inventory On Hand265263367
Slightly volatile
Payables Turnover1.741.661.4575
Pretty Stable
Sales General And Administrative To Revenue0.560.592.7503
Slightly volatile
Average Inventory12.6 K13.3 K239.9 K
Slightly volatile
Research And Ddevelopement To Revenue0.270.291.6006
Slightly volatile
Capex To Revenue0.180.170.101
Very volatile
Cash Per Share2.141.252.2646
Pretty Stable
Days Payables Outstanding286227375
Slightly volatile
Net Current Asset Value2.9 M2.2 M2.5 M
Very volatile
Income Quality0.920.910.8998
Slightly volatile
Tangible Asset Value4.1 M2.4 M2.8 M
Slightly volatile
Intangibles To Total Assets0.07630.08040.0561
Slightly volatile
Current Ratio3.093.256.1931
Pretty Stable
Receivables Turnover8.436.184.9875
Slightly volatile
Shareholders Equity Per Share0.190.22.3518
Slightly volatile
Debt To Equity9.669.21.7696
Slightly volatile
Capex Per Share0.340.320.0879
Slightly volatile
Average Receivables467.9 K238.2 K572.2 K
Slightly volatile
Revenue Per Share2.352.231.0805
Slightly volatile
Interest Debt Per Share3.72.280.5899
Slightly volatile
Debt To Assets0.550.520.1262
Slightly volatile
Graham Number77.1486.7994.7306
Slightly volatile
Operating Cycle545414485
Slightly volatile
Price Book Value Ratio69.5966.2818.1284
Slightly volatile
Days Of Payables Outstanding286227375
Slightly volatile
Ebt Per Ebit2.341.261.094
Slightly volatile
Company Equity Multiplier16.7415.954.0316
Slightly volatile
Long Term Debt To Capitalization0.850.810.3137
Slightly volatile
Total Debt To Capitalization0.860.820.1877
Slightly volatile
Debt Equity Ratio9.669.21.7696
Slightly volatile
Quick Ratio2.72.845.8576
Pretty Stable
Net Income Per E B T1.571.151.0055
Slightly volatile
Cash Ratio0.760.83.883
Pretty Stable
Days Of Inventory Outstanding265263367
Slightly volatile
Days Of Sales Outstanding74.2578.15102
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.71.070.9805
Slightly volatile
Price To Book Ratio69.5966.2818.1284
Slightly volatile
Fixed Asset Turnover4.044.2610.3396
Slightly volatile
Debt Ratio0.550.520.1262
Slightly volatile
Price Sales Ratio5.635.9329.3442
Slightly volatile
Asset Turnover0.760.730.3203
Slightly volatile
Price Fair Value69.5966.2818.1284
Slightly volatile

Avita Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap190.1 M298.2 M254.4 M
Slightly volatile
Working Capital3.1 M2.3 M2.6 M
Pretty Stable
Enterprise Value343.3 M326.9 M248.3 M
Slightly volatile

Avita Fundamental Market Drivers

Forward Price Earnings4.8193
Cash And Short Term Investments35.9 M

Avita Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Avita Medical Financial Statements

Avita Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Avita Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue38 K36.1 K
Total Revenue73.9 M77.6 M
Cost Of Revenue10.5 M11 M
Stock Based Compensation To Revenue 0.24  0.23 
Sales General And Administrative To Revenue 0.59  0.56 
Research And Ddevelopement To Revenue 0.29  0.27 
Capex To Revenue 0.17  0.18 
Revenue Per Share 2.23  2.35 
Ebit Per Revenue(0.79)(0.83)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Avita Medical is a strong investment it is important to analyze Avita Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avita Medical's future performance. For an informed investment choice regarding Avita Stock, refer to the following important reports:
How To Invest In Avita
Details
Is Avita Stock a good investment?
Details
What is Avita Medical's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Avita Medical Correlation against competitors.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.81)
Revenue Per Share
2.702
Quarterly Revenue Growth
(0.13)
Return On Assets
(0.36)
Return On Equity
(17.46)
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY